Chemical Peel for Skin Rejuvenation - Quick Reference Sheet

Chemical Peel for Skin Rejuvenation

Created on 07/31/2026 – Quick Reference based on Evidence Review created using AI4L / Grok 4 Audit

Chemical peels are controlled acid resurfacing used to improve sun damage, uneven pigment, rough texture, and acne-related marks. Evidence supports clear benefit for mild-to-moderate acne and useful, sometimes secondary roles in pigment and sun-driven aging when depth matches skin type. Superficial peels offer modest cumulative gains with low downtime; deeper peels remodel more but raise lasting pigment and scarring risk. (Full Review)

Protocol

Superficial series
4–6 sessions
Every 2–5 weeks; glycolic 20–70%, salicylic 20–30%, light TCA, or Jessner's
Medium-depth
Jessner's + 35% TCA
Recovery ~7–14 days; moderate photoaging and actinic damage
Deep peels
Phenol-based
Specialized settings only; severe rhytides; carefully selected lighter-skinned patients
Time to effect
Deep peels
Weeks to months
Dramatic change after prolonged healing; redness may settle over months
Medium peels
Weeks
Improvement as erythema fades and remodeling proceeds
Superficial peels
Days to weeks
Brighter texture; cumulative across a series

Benefits

Contraindications
  • Pregnancy and breastfeeding (many agents/practices; melasma volatility)
  • Active herpes, bacterial infection, or open facial wounds in the treatment field
  • Unrealistic expectations or inability to follow photoprotection/aftercare
  • Deep peels: darker Fitzpatrick types, significant hepatorenal disease, or poor cardiac status (phenol)
  • History of keloid tendency (medium/deep peels)
  • Recent deep peels or ablative lasers without adequate healing interval
Key Interactions
  • Oral isotretinoin within months (relative; medium–deep peels)
  • Topical retinoids (tretinoin): usually paused shortly before peel day
  • Photosensitizing medications (e.g., doxycycline, tetracycline, hydrochlorothiazide)
  • Anticoagulants / antiplatelets (deeper peels with oozing)
  • OTC facial actives (benzoyl peroxide, high-strength AHA/BHA, abrasive scrubs)
  • Hydroquinone and pigment-control topicals (irritation; long-term ochronosis risk)
  • Other resurfacing (laser, microneedling, dermabrasion) without adequate spacing
  • High-dose vitamin E or fish oil peri-procedure (theoretical)

Risk & Side Effects

  • High: Expected healing reaction; post-inflammatory hyperpigmentation
  • Medium: Hypopigmentation; scarring; herpes simplex reactivation
  • Low: Infection; phenol-related systemic toxicity; ocular injury
  • Speculative: Cumulative barrier impairment from overly frequent peeling; delayed wound healing with concurrent isotretinoin

Monitoring

Marker Target Why
Standardized facial photography Comparable series; improved texture/tone vs baseline Objective visual track of rejuvenation
Investigator/patient global aesthetic scales Improvement of ≥1 grade when used Captures overall success
MASI or equivalent (if melasma) Downward trend vs baseline Tracks pigment-focused peels
Acne lesion counts (if acne indication) Reduced inflammatory and noninflammatory counts Documents peel series effect
Fitzpatrick type (baseline classification) Documented I–VI Guides depth/PIH risk
Wound-healing status Re-epithelialized without infection/scarring Safety gate for next peel
Pregnancy test (when relevant) Negative before elective peel Avoid fetal/unknown risk exposure
Cardiac monitoring (phenol only) Stable rhythm during procedure Detect phenol-related arrhythmia

Cadence: Healing check day 3–7 (superficial) or through re-epithelialization (medium/deep); series reassessment every 1–2 peels with photography; maintenance every 3–6 months

Qualitative Assessment

  • Smoother feel to makeup application or bare skin
  • More even tone in natural light
  • Reduced visibility of fine lines at rest
  • Tolerable downtime consistent with peel depth chosen
  • Absence of lasting dark or light patches relative to surrounding skin